NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Encore Medical, Inc.

Encore Medical, Inc.

EMINYSEAMERICAN
upcoming

Issue Size

$15.00M

Price Range

$5.00

Shares

9.74M o/s · 3M offered

Listing Price

$5.00

Sector

Healthcare

About

Encore Medical, Inc.

Encore Medical is a structural heart device company dedicated to the transcatheter closure of certain cardiac defects.We develop, manufacture, and market septal occlusion products, which are small, implantable devices delivered through a catheter inserted into a major blood vessel to permanently repair certain cardiac defects.

Our devices include patented technology that has been in use extensively outside of the U.S.

Procedures are performed in a cardiac catheterization lab and reduce the need for open heart surgery or a lifetime of drug therapy, which are currently the primary alternative methods for treating these defects.

We have developed devices capable of providing effective, nonsurgical methods of correcting a variety of cardiac defects in both adults and children.

Encore Medical, Inc. Overview

Ticker, listing venue and issuer profile

TickerEMI
ExchangeNYSEAMERICAN
Statusupcoming
SectorHealthcare
IndustryMedical Devices
CurrencyUSD
CIK Code1838003
CUSIP--
ISINUS2925951053

Offer & Key Dates

Pricing terms and IPO milestones

Price Range$5.00
Offer Price$5.00
Listing Price--
Current Price--
Shares Offered3M
Shares Outstanding9.74M
Offer Size$15.00M
Market Cap$48.72M
Filing Date--
Priced Date--
Listed Date--

Valuation & Multiples

Key valuation ratios and metrics

P / E--
P / Book--
P / Sales--
EV / EBITDA--
EPS--
Revenue / Share (TTM)--
Revenue$2.59M
Net Income-$928.09K

Financial Health

Balance sheet strength and liquidity

Total Debt$1.86M
Total Assets$2.16M
Cash$94.26K
Free Cash Flow--
Current Ratio0.51
Quick Ratio0.43
Debt / Equity--
CapEx--

Profitability & Returns

Margins and return on capital

Gross Margin--
Operating Margin--
Net Margin--
Return on Equity--
Return on Assets-51.41%
ROIC--
EBITDA--
Gross Profit$1.04M

Financial Highlights

Historical financial performance

SEC Filings

Official documents from SEC EDGAR

Company Info

Contact and headquarters details

HeadquartersUnited States
Founded2017
Employees16
Phone(651) 797-0913
Address2975 Lone Oak Drive, Suite 140Eagan, MN 55121United States

Leadership

Key executives and officers

JA

Joseph A. Marino

Chairman of the Board of Directors, President and Chief Executive Officer

PM

Peter M. Buonomo

Senior Vice President, Director

SS

Scott S. Robinson

Treasurer

TG

Timothy G. Laske, PhD

Director

CJ

Christopher J. Turnbull

Director

TC

Todd C. Johnson

Director

Encore Medical, Inc. IPO - FAQs

IPO (initial public offering) is the process through which a private company offers its shares to the public for the first time to raise equity capital from a broader base of public investors.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.